Skip to main content
SpringerLink
Log in
Book cover

Lung Cancer pp 465–480Cite as

Lung-Specific Expression of Mutant p53 as Mouse Model for Lung Cancer

  • Protocol

  • 840 Accesses

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 74))

Abstract

The p53 tumor suppressor gene is the most commonly mutated gene in cancer (1,2) and is mutated in 50% non-small cell lung cancer (NSCLC) and 70% of small cell lung cancer (SCLC) (3). Mutations in p53 commonly reflect exposures to environmental carcinogens, e.g., cigarette smoke and lung cancer or aflatoxin and liver cancer. In support for tobacco smoking as a major risk factor for lung cancer, as the content of tar and nicotine per cigarette has dropped by more than two-thirds, there has been a concomitant change in the histologic type of lung cancer (4). While SCLC has persisted at about 20%, adenocarcinoma has increased to 45% with declines in squamous cell and large cell carcinoma. Thun and colleagues (5) have suggested that these changes are due to the design of the cigarette; e.g., filter-tip cigarettes are inhaled more deeply than earlier, unfiltered cigarettes (more toxic), and deeper inhalation transports tobacco-specific carcinogens more distally toward the bronchoalveolar junction where adenocarcinomas often arise. In human lung cancer, both the frequency and type of mutations in the p53 gene can act as fingerprints providing information about external etiological agents, carcinogen exposure, and host factors affecting the carcinogenesis process (6).

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Levine, A. J., Momand, J., and Finlay, C. A. (1991) The p53 tumour suppressor gene. Nature 351, 453–456.

    Article  PubMed  CAS  Google Scholar 

  2. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307–310.

    Article  PubMed  CAS  Google Scholar 

  3. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Muta-tions in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855–4878.

    PubMed  CAS  Google Scholar 

  4. Fielding J. E. (1985) Smoking: health effects and control. N. Engl. J. Med. 313, 491–498, 555–562.

    Article  PubMed  CAS  Google Scholar 

  5. Thun, M. J., Lally, C. A., Flannery J. T., Calle, E. E., Flanders, W. D., and Heath, C. W. (1997) Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89, 1580–1586.

    Article  PubMed  CAS  Google Scholar 

  6. Bartsch, H. and Hietanen, E. (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect. 104S3, 569–577.

    Google Scholar 

  7. Hernandez-Boussard, T. M. and Hainaut, P. (1998) A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ. Health Perspect. 106, 385–391.

    Article  PubMed  CAS  Google Scholar 

  8. Harris, C. C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88, 1442–1455.

    Article  PubMed  CAS  Google Scholar 

  9. Denissenko, M. F., Pao, A., Tang, M. S., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274, 430–432.

    Article  PubMed  CAS  Google Scholar 

  10. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238.

    Article  PubMed  CAS  Google Scholar 

  11. Malkinson, A. M. (1998) Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res. 24, 541–555.

    Article  PubMed  CAS  Google Scholar 

  12. Herzog, C. R., Lubet, R. A., and You, M. (1997) Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J. Cell Biochem. Suppl. 28-29, 49–63.

    Article  PubMed  CAS  Google Scholar 

  13. Serrano, M. (2000) The INK4α/ARF locus in murine tumorigenesis. Carcinogen-esis 21, 865–869.

    Article  CAS  Google Scholar 

  14. You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. (1989) Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA 86, 3070–3074.

    Article  PubMed  CAS  Google Scholar 

  15. Mass, M. J., Jeffers, A. J., Ross, J. A., Nelson, G., Galati, A. J., Stoner, G. D., and Nesnow, S. (1993) Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinogenesis 8, 186–192.

    Article  CAS  Google Scholar 

  16. Shafarenko, M., Mahler, J., Cochran C., Kisielewski, A., Golding, E., Wiseman, R., and Goodrow, T. (1997) Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. Carcinogenesis 18, 1423–1426.

    Article  PubMed  CAS  Google Scholar 

  17. Lubet, R. A., Zhang, Z., Wiseman, R. W., and You, M. (2000) Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp. Lung Res. 26, 581–593.

    Article  PubMed  CAS  Google Scholar 

  18. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221.

    Article  PubMed  CAS  Google Scholar 

  19. Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., and Donehower, L. A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225–229.

    Article  PubMed  CAS  Google Scholar 

  20. Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E. M., et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603–609.

    PubMed  CAS  Google Scholar 

  21. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bernstein, A. (1989) High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9, 3982–3991.

    PubMed  CAS  Google Scholar 

  22. Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A., and Donehower, L. A. (1995) A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9, 305–311.

    Article  PubMed  CAS  Google Scholar 

  23. Zhang, Z., Liu, Q., Lantry, L. E., Wang, Y., Kelloff, G. J., Anderson, M. W., et al. (2000) A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/ myo-inositol and chemotherapeutic agents taxol or adramycin. Cancer Res. 60, 901–907.

    PubMed  CAS  Google Scholar 

  24. Yoshimoto, T., Inoue, T., Iizuka, H., Nishikawa, H., Sakatani, M., Ogura, T., et al. (1980) Differential induction of squamous cell carcinomas and adenocarcinomas in mouse lung by intratracheal instillation of benzo(a)pyrene and charcoal powder. Cancer Res. 40, 4301–4307.

    PubMed  CAS  Google Scholar 

  25. Morris G.F., Hoyle G. W., Athas G.B., Lei W. H., Xu, J., Morris C. B.,and Fried-man, M. (1998) Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein. J. LA. State Med. Soc. 150, 179–185.

    PubMed  CAS  Google Scholar 

  26. Hosokawa, A. (1999) Generation and analyses of transgenic mice containing mutant p53 transgene. Jukuoka Igaku Zasshi 90, 80–87.

    CAS  Google Scholar 

  27. Magdaleno, S. M., Wang, G., Mireles, V. L., Ray, M. K., Finegold, M. J., and DeMayo, F. J. (1997) Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 Large T Antigen in transgenic mice. Cell Growth Differ. 8, 145–155.

    PubMed  CAS  Google Scholar 

  28. Wikenheiser, K. A., Clark, J. C., Linnoila, R. I., Stahlman, M. T., and Whitsett, J. A. (1992) Simian Virus 40 Large T Antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res. 52, 5342–5352.

    PubMed  CAS  Google Scholar 

  29. Wikenheiser, K. A. and Whitsett, J. A. (1997) Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 Large T Antigen transgenic mice. Am. J. Respir. Cell Mol. Biol. 16, 713–723.

    PubMed  CAS  Google Scholar 

  30. Pack, R. J., Al-Ugaily, L. H., and Morris, G. (1981) The cells of the tracheobron-chial epithelium of the mouse: a quantitative light and electron microscope study. J.Anat. 132 (Pt 1), 71–84.

    PubMed  CAS  Google Scholar 

  31. Shaulian, E., Zauberman, A., Ginsberg, D., and Oren, M. (1992) Identification of a minimal transformation domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12, 5581–5592.

    PubMed  CAS  Google Scholar 

  32. Sawaya, P. L., Stripp, B. R., Whitsett, J. A., and Luse, D. S. (1993) The lung-specific CC10 gene is regulated by transcription factors from the AP-1, octamer, and hepatocyte nuclear factor 3 families. Mol. Cell. Biol. 13, 3860–3871.

    PubMed  CAS  Google Scholar 

  33. Bowman, T., Symonds, H., Gu, L., Yin, C., Oren, M., and Van Dyke, T. (1996) Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev. 10, 826–835.

    Article  PubMed  CAS  Google Scholar 

  34. Nomori, H., Morinaga, S., Kobayashi, R., and Torikata, C. (1994) Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system. Virchows Arch. 424, 517–523.

    Article  PubMed  CAS  Google Scholar 

  35. Szabo, E., Goheer, A., Witschi, H., and Linnoila, R. I. (1998) Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ. 9, 475–485.

    PubMed  CAS  Google Scholar 

  36. Linnoila, R. I., Szabo, E., DeMayo, F., Witschi, H., Sabourin, C., and Malkinson, A. (2000) the role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann. NY Ac ad. Sci. 923, 249–267.

    Article  CAS  Google Scholar 

  37. Margraf, L. R., Finegold, M. J., Stanley, L. A., Major, A., Hawkins, H. K., and DeMayo, E J. (1993) Cloning and tissue-specific expression of the cDNA for 480 the mouse Clara cell 10 kD protein: comparison of endogenous expression to rabbit uteroglobin promoter-driven transgene expression. Am. J. Respir. Cell Mol. Biol. 9, 231–238.

    PubMed  CAS  Google Scholar 

  38. Ray, M. K., Magdaleno, S. W., Finegold, M. J., and DeMayo, F. J. (1995) cis-acting elements involved in the regulation of mouse Clara cell-specific 10-kDa protein gene. In vitro and in vivo analysis. J. Biol. Chem. 270, 2689–2694.

    Article  PubMed  CAS  Google Scholar 

  39. Ray, M. K., Chen, C. Y., Schwartz, R. J., and DeMayo, F. J. (1996) Transcriptional regulation of a mouse Clara cell-specific protein (mCC10) gene by the NKx transcription factor family members thyroid transciption factor 1 and cardiac muscle-specific homeobox protein (CSX). Mol. Cell. Biol. 16, 2056–2064.

    PubMed  CAS  Google Scholar 

  40. Mahler, J. F., Stokes, W., Mann, P. C., Takaoka, M., and Maronpot, R. R. (1996) Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24, 710–716.

    Article  PubMed  CAS  Google Scholar 

  41. Zhan, B., Magdaleno, S., Chua, S., Wang, Y. L., Burcin, M., Elberg, D., et al. (2000) Transgenic mouse models for lung cancer. Exp. Lung Res. 26, 567–579.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Pulmonary and Critical Care Medicine, NYU School of Medicine, New York, NY

    Kam-Meng Tchou-Wong

  2. Bellevue Chest Service, NYU Medical Center and Division of Pulmonary and Critical Care Medicine, Department of Medicine, NYU School of Medicine, New York, NY

    William N. Rom

Authors
  1. Kam-Meng Tchou-Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William N. Rom
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Children’s Hospital, Los Angeles, CA, USA

    Barbara Driscoll PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Tchou-Wong, KM., Rom, W.N. (2003). Lung-Specific Expression of Mutant p53 as Mouse Model for Lung Cancer. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 74. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-323-2:465

Download citation

  • DOI: https://doi.org/10.1385/1-59259-323-2:465

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-0-89603-985-8

  • Online ISBN: 978-1-59259-323-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation